nodes	percent_of_prediction	percent_of_DWPC	metapath
Lindane—Dermatitis contact—Isotretinoin—peripheral nervous system neoplasm	0.0455	0.0455	CcSEcCtD
Lindane—Dermatitis contact—Tretinoin—peripheral nervous system neoplasm	0.0455	0.0455	CcSEcCtD
Lindane—Dermatitis contact—Alitretinoin—peripheral nervous system neoplasm	0.0345	0.0345	CcSEcCtD
Lindane—Alopecia—Topotecan—peripheral nervous system neoplasm	0.0206	0.0206	CcSEcCtD
Lindane—Alopecia—Tretinoin—peripheral nervous system neoplasm	0.0204	0.0204	CcSEcCtD
Lindane—Alopecia—Isotretinoin—peripheral nervous system neoplasm	0.0204	0.0204	CcSEcCtD
Lindane—Alopecia—Melphalan—peripheral nervous system neoplasm	0.0202	0.0202	CcSEcCtD
Lindane—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.0174	0.0174	CcSEcCtD
Lindane—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.0174	0.0174	CcSEcCtD
Lindane—Convulsion—Melphalan—peripheral nervous system neoplasm	0.0172	0.0172	CcSEcCtD
Lindane—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.0167	0.0167	CcSEcCtD
Lindane—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.0155	0.0155	CcSEcCtD
Lindane—Dermatitis contact—Epirubicin—peripheral nervous system neoplasm	0.0151	0.0151	CcSEcCtD
Lindane—Alopecia—Vincristine—peripheral nervous system neoplasm	0.0149	0.0149	CcSEcCtD
Lindane—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.0149	0.0149	CcSEcCtD
Lindane—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.0147	0.0147	CcSEcCtD
Lindane—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.0147	0.0147	CcSEcCtD
Lindane—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.0145	0.0145	CcSEcCtD
Lindane—Pain—Topotecan—peripheral nervous system neoplasm	0.0142	0.0142	CcSEcCtD
Lindane—Pain—Tretinoin—peripheral nervous system neoplasm	0.014	0.014	CcSEcCtD
Lindane—Pain—Isotretinoin—peripheral nervous system neoplasm	0.014	0.014	CcSEcCtD
Lindane—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.014	0.014	CcSEcCtD
Lindane—Pain—Melphalan—peripheral nervous system neoplasm	0.0139	0.0139	CcSEcCtD
Lindane—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.0132	0.0132	CcSEcCtD
Lindane—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.0132	0.0132	CcSEcCtD
Lindane—Urticaria—Topotecan—peripheral nervous system neoplasm	0.0131	0.0131	CcSEcCtD
Lindane—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Lindane—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Lindane—Urticaria—Melphalan—peripheral nervous system neoplasm	0.0129	0.0129	CcSEcCtD
Lindane—Convulsion—Vincristine—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Lindane—Alopecia—Etoposide—peripheral nervous system neoplasm	0.0121	0.0121	CcSEcCtD
Lindane—Pruritus—Topotecan—peripheral nervous system neoplasm	0.0117	0.0117	CcSEcCtD
Lindane—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Lindane—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Lindane—Pain—Dactinomycin—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Lindane—Pruritus—Melphalan—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Lindane—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.0113	0.0113	CcSEcCtD
Lindane—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.0112	0.0112	CcSEcCtD
Lindane—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0109	0.0109	CcSEcCtD
Lindane—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0109	0.0109	CcSEcCtD
Lindane—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0109	0.0109	CcSEcCtD
Lindane—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.0108	0.0108	CcSEcCtD
Lindane—Pain—Alitretinoin—peripheral nervous system neoplasm	0.0106	0.0106	CcSEcCtD
Lindane—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.0104	0.0104	CcSEcCtD
Lindane—Headache—Topotecan—peripheral nervous system neoplasm	0.0104	0.0104	CcSEcCtD
Lindane—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Lindane—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Lindane—Convulsion—Etoposide—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Lindane—Headache—Tretinoin—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Lindane—Headache—Isotretinoin—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Lindane—Pain—Vincristine—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Lindane—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0102	0.0102	CcSEcCtD
Lindane—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00988	0.00988	CcSEcCtD
Lindane—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00952	0.00952	CcSEcCtD
Lindane—Pain—Cisplatin—peripheral nervous system neoplasm	0.00906	0.00906	CcSEcCtD
Lindane—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0088	0.0088	CcSEcCtD
Lindane—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00872	0.00872	CcSEcCtD
Lindane—Pain—Etoposide—peripheral nervous system neoplasm	0.0083	0.0083	CcSEcCtD
Lindane—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00823	0.00823	CcSEcCtD
Lindane—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00793	0.00793	CcSEcCtD
Lindane—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00784	0.00784	CcSEcCtD
Lindane—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00779	0.00779	CcSEcCtD
Lindane—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00771	0.00771	CcSEcCtD
Lindane—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00755	0.00755	CcSEcCtD
Lindane—Headache—Vincristine—peripheral nervous system neoplasm	0.00751	0.00751	CcSEcCtD
Lindane—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00687	0.00687	CcSEcCtD
Lindane—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00677	0.00677	CcSEcCtD
Lindane—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00668	0.00668	CcSEcCtD
Lindane—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00642	0.00642	CcSEcCtD
Lindane—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.00626	0.00626	CcSEcCtD
Lindane—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00612	0.00612	CcSEcCtD
Lindane—Headache—Etoposide—peripheral nervous system neoplasm	0.00608	0.00608	CcSEcCtD
Lindane—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00578	0.00578	CcSEcCtD
Lindane—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00535	0.00535	CcSEcCtD
Lindane—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00489	0.00489	CcSEcCtD
Lindane—Pain—Epirubicin—peripheral nervous system neoplasm	0.00465	0.00465	CcSEcCtD
Lindane—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00452	0.00452	CcSEcCtD
Lindane—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00432	0.00432	CcSEcCtD
Lindane—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00431	0.00431	CcSEcCtD
Lindane—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Lindane—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00385	0.00385	CcSEcCtD
Lindane—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.0036	0.0036	CcSEcCtD
Lindane—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Lindane—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00343	0.00343	CcSEcCtD
Lindane—Headache—Epirubicin—peripheral nervous system neoplasm	0.00341	0.00341	CcSEcCtD
Lindane—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Lindane—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Lindane—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
